Cross Atlantic Partners

Investment Portfolio

We focus on companies that are well beyond proof-of-principle in their technology, markets and products.

 

Except for exceptional information companies, we do not participate in the first round of investment.

IMPATH, Inc.

ILEX Oncology, Inc.

Gene Logic, Inc.

SunPharm Corporation

NOMOS Corporation

Martek Biosciences Corporation

AirLogix Corporation

Eximias Pharmaceutical Corp.

Galt Associates, Inc.

Confluent Surgical, Inc.

Nutrition 21, Inc.

Medivance, Inc.

Acorda Therapeutics, Inc.

Labcyte, Inc.

GenomeQuest, Inc.

BioMedical Enterprises, Inc.

LifeMed Media, Inc.

MDx Medical LLC

Palyon Medical Corp.

IntegriChain, Inc.

Selected Completed

Active